Squarepoint’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-16,700
Closed -$20K 3750
2022
Q3
$20K Sell
16,700
-23,658
-59% -$36.9K ﹤0.01% 2912
2022
Q2
$73K Sell
40,358
-215,383
-84% -$318K ﹤0.01% 2672
2022
Q1
$517K Buy
255,741
+193,245
+309% +$380K ﹤0.01% 1989
2021
Q4
$169K Sell
62,496
-88,595
-59% -$328K ﹤0.01% 2773
2021
Q3
$674K Buy
151,091
+6,022
+4% +$29K ﹤0.01% 1797
2021
Q2
$841K Buy
145,069
+74,148
+105% +$434K ﹤0.01% 1764
2021
Q1
$498K Sell
70,921
-41,936
-37% -$281K ﹤0.01% 2023
2020
Q4
$542K Buy
+112,857
New +$571K ﹤0.01% 1759
2020
Q2
Sell
-43,908
Closed -$279K 2613
2020
Q1
$279K Sell
43,908
-31,827
-42% -$255K 0.01% 1328
2019
Q4
$790K Sell
75,735
-217,109
-74% -$1.58M ﹤0.01% 1484
2019
Q3
$1.15M Buy
292,844
+251,881
+615% +$2.04M 0.01% 1135
2019
Q2
$609K Buy
40,963
+10,044
+32% +$181K 0.01% 1547
2019
Q1
$767K Sell
30,919
-48,066
-61% -$1.2M 0.01% 1239
2018
Q4
$1.42M Buy
78,985
+72,116
+1,050% +$1.47M 0.02% 798
2018
Q3
$202K Sell
6,869
-33,467
-83% -$1.3M ﹤0.01% 1770
2018
Q2
$1.83M Buy
40,336
+34,136
+551% +$1.66M 0.02% 668
2018
Q1
$327K Sell
6,200
-4,293
-41% -$250K 0.01% 1277
2017
Q4
$714K Buy
+10,493
New +$734K 0.01% 987
2017
Q3
Sell
-2,700
Closed -$253K 1966
2017
Q2
$253K Buy
+2,700
New +$165K 0.01% 1211
2017
Q1
Sell
-20,813
Closed -$925K 2016
2016
Q4
$925K Buy
20,813
+13,813
+197% +$486K 0.04% 540
2016
Q3
$252K Buy
+7,000
New +$150K 0.02% 806
2016
Q1
Sell
-16,000
Closed -$560K 1525
2015
Q4
$560K Buy
+16,000
New +$1.03M 0.06% 477

Other funds holding CLVS